We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$4.3B
AUM Growth
+$519M
Cap. Flow
-$26.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
43.48%
Holding
487
New
10
Increased
143
Reduced
81
Closed
22
Avg Time Held
20.8 quarters
Top 10 Avg Time Held
24 quarters
Top 20 Avg Time Held
16.2 quarters

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$38.6M
2
SYK icon
Stryker
SYK
+$37.7M
3
COF icon
Capital One
COF
+$33.6M
4
DOV icon
Dover
DOV
+$31M
5
RDNT icon
RadNet
RDNT
+$23.4M

Top Sells

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$56.7M
2
GILD icon
Gilead Sciences
GILD
+$44.4M
3
T icon
AT&T
T
+$34.8M
4
INTU icon
Intuit
INTU
+$32.5M
5
BSX icon
Boston Scientific
BSX
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 43.83%
2 Financials 13.15%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DGX icon
326
Quest Diagnostics
DGX
$25.4B
$837K 0.02%
3,950
– –
2019 Q4
26 quarters
DG icon
327
Dollar General
DG
$27.6B
$833K 0.02%
7,238
– –
2023 Q3
11 quarters
INSM icon
328
Insmed
INSM
$21.1B
$830K 0.02%
7,789
+2,550
+49% +$309K
2025 Q4
2 quarters
HUBB icon
329
Hubbell
HUBB
$25.3B
$828K 0.02%
1,583
– –
2022 Q4
14 quarters
VRSK icon
330
Verisk Analytics
VRSK
$23B
$824K 0.02%
4,592
– –
2013 Q2
52 quarters
UTHR icon
331
United Therapeutics
UTHR
$23.3B
$824K 0.02%
1,521
– –
2025 Q4
2 quarters
LII icon
332
Lennox International
LII
$12.1B
$823K 0.02%
1,437
+500
+53% +$255K
2017 Q2
36 quarters
LPLA icon
333
LPL Financial
LPLA
$25.6B
$821K 0.02%
2,916
– –
2022 Q2
16 quarters
CPRT icon
334
Copart
CPRT
$24.4B
$818K 0.02%
29,023
– –
2019 Q2
28 quarters
CINF icon
335
Cincinnati Financial
CINF
$25.4B
$812K 0.02%
4,384
– –
2025 Q4
2 quarters
AWK icon
336
American Water Works
AWK
$25.8B
$809K 0.02%
6,151
– –
2013 Q2
52 quarters
RF icon
337
Regions Financial
RF
$23B
$808K 0.02%
26,753
– –
2018 Q3
31 quarters
TSCO icon
338
Tractor Supply
TSCO
$17.6B
$808K 0.02%
25,550
– –
2013 Q2
52 quarters
ULTA icon
339
Ulta Beauty
ULTA
$24.8B
$782K 0.02%
1,735
– –
2013 Q2
52 quarters
ZM icon
340
Zoom
ZM
$28.6B
$781K 0.02%
9,050
– –
2025 Q4
2 quarters
SBAC icon
341
SBA Communications
SBAC
$19.3B
$773K 0.02%
4,383
– –
2019 Q4
26 quarters
CDW icon
342
CDW
CDW
$19B
$768K 0.02%
5,463
+1,800
+49% +$226K
2025 Q4
2 quarters
Q icon
343
Qnity Electronics Inc
Q
$25.7B
$767K 0.02%
4,697
– –
2025 Q4
2 quarters
MKL icon
344
Markel Group
MKL
$22.2B
$752K 0.02%
385
– –
2024 Q4
6 quarters
VRSN icon
345
VeriSign
VRSN
$27.3B
$751K 0.02%
2,985
– –
2025 Q4
2 quarters
KHC icon
346
The Kraft Heinz Company
KHC
$26.6B
$749K 0.02%
31,726
– –
2022 Q3
15 quarters
RVMD icon
347
Revolution Medicines
RVMD
$40.4B
$749K 0.02%
4,000
– –
2026 Q1
1 quarter
BURL icon
348
Burlington
BURL
$16.5B
$748K 0.02%
2,360
– –
2018 Q4
30 quarters
BR icon
349
Broadridge
BR
$19B
$746K 0.02%
5,450
– –
2022 Q1
17 quarters
COIN icon
350
Coinbase
COIN
$48B
$741K 0.02%
5,072
– –
2025 Q4
2 quarters
12 13
14
15 16

Similar funds

AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.3B AUM 24.01% 1-Year Est. Return
GHC
Great Hill Capital New York $4.29B AUM 18.17% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $4.28B AUM 19.27% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return

E. Ohman J:or Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, E. Ohman J:or Asset Management held 487 positions worth $4.3B, up 14% from $3.78B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

E. Ohman J:or Asset Management's Q2 2026 filing shows 10 new, 143 increased, 81 reduced and 22 closed positions. Its largest new stake was Denali Therapeutics: 160,000 shares worth $4.12M. The largest sale was Cboe Global Markets, an estimated $56.7M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.

  • E. Ohman J:or Asset Management's largest Q2 2026 buy was Denali Therapeutics: 160,000 shares worth $4.12M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q2 2026, an estimated $38.6M increase.
  • E. Ohman J:or Asset Management's biggest Q2 2026 reduction was Cboe Global Markets, cutting an estimated $56.7M.
  • E. Ohman J:or Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $1.17M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 43% of its $4.3B portfolio in Q2 2026.
  • E. Ohman J:or Asset Management opened 10 new positions and closed 22 in Q2 2026.
  • E. Ohman J:or Asset Management's portfolio value rose 14% quarter-over-quarter to $4.3B.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.